Back to search
Drug Resistance, Microbial
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Drug Resistance, Microbial trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Drug Resistance, Microbial trials you may qualify forDespite widespread recognition of social, economic, or environmental health determinants, health action remains heavily dominated by individual-level solutions…
The purpose of this study is to assess the safety, tolerability and pharmacokinetics of single and multiple intravenous doses of BWC0977 when administered to he…
The aim of this research experiment is to evaluate the effectiveness of fecal microbiota transplantation (FMT) preceded by antibiotic pre-treatment versus probi…
Two commonly used treatments for latent tuberculosis infection are either 4 months rifampicin or 6-9 months isoniazid. The invistigators will study the risk of…
The goal of this observational study is to investigate how bacterial populations from the intestine and mouth of patients change during the hospitalization peri…
The clinical management of H. pylori infection depends essentially on two factors, prevalence and local resistance. In Germany, only limited data from rather sm…
The purpose of this study is to evaluate the effect of a peer comparison feedback report, combined with a best practices toolkit, on the volume of antimicrobial…
The goal of this study is to evaluate an educational intervention that aims to reduce the number of unnecessary antibiotics prescribed by family physicians and…
"Candida auris is an emerging fungus that can cause severe infections, particularly in hospitalized patients, and is often resistant to multiple antifungal trea…